All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. [Breast cancer screening]

    KCE Reports 11 (2005)

    https://kce.fgov.be/en/breast-cancer-screening

  2. [The Cost of Dental Prostheses]

    KCE Reports 10 (2005)

    https://kce.fgov.be/en/the-cost-of-dental-prostheses

  3. [Feedback : research on impact and barriers for implementation – Research report : Part I]

    KCE Reports 9 (2005)

    https://kce.fgov.be/en/feedback-research-on-impact-and-barriers-for-implementation-%E2%80%93-research-report-part-i

  4. [Financing of hospital drugs: a descriptive study of several European countries and Canada]

    KCE Reports 8 (2005)

    https://kce.fgov.be/en/financing-of-hospital-drugs-a-descriptive-study-of-several-european-countries-and-canada

  5. [Validation of the Report of the Research Commission of Underfinancing of Hospitals]

    KCE Reports 7 (2004)

    https://kce.fgov.be/en/validation-of-the-report-of-the-research-commission-of-underfinancing-of-hospitals

  6. [National recommandation for prenatal care. A base for a clinical pathway aimed at following pregnancy]

    KCE Reports 6 (2004) This report was updated (30/06/2015). This is no longer available for download, but can be obtained on request. Thank you to check out the latest version: KCE Reports 248: What are the recommended clinical assessment and screening tests during pregnancy?

    https://kce.fgov.be/en/national-recommandation-for-prenatal-care-a-base-for-a-clinical-pathway-aimed-at-following-pregnancy

  7. [Preoperative risk assessment]

    KCE Reports 5 (2004) The routine peri-operative use of beta-blockers is no longer recommended In the KCE guidelines on pre-surgical examinations (KCE Reports 5-2004), the peri-operative use of beta-blockers (see page 10) was elaborately discussed. These recommendations were largely based on primary studies  To this date (February 2014), it appears that most of these studies are fraudulent. KCE therefore questions the peri-operative  administration of these agents. For more information: http://www.escardio.org/about/press/press-releases/pr-13/Pages/joint-statement-per

    https://kce.fgov.be/en/preoperative-risk-assessment

  8. [Leukoreduction. A possible measure in the context of a national blood safety policy]

    KCE Reports 4 (2004)

    https://kce.fgov.be/en/leukoreduction-a-possible-measure-in-the-context-of-a-national-blood-safety-policy

  9. [Antibiotics use in hospitals for acute pyelonephritis]

    KCE Reports 3 (2004)

    https://kce.fgov.be/en/antibiotics-use-in-hospitals-for-acute-pyelonephritis

  10. [Study on the potential cost of a modification of the legislation concerning medical liability (Phase I)]

    KCE Reports 2 (2004) [Phase I : Evaluation of the recquired statistical datas to set up an health care policy related to medical hazards and to allow a budgetary evaluation of the new indemnification system for medical errors and therapeurical hazards]

    https://kce.fgov.be/en/study-on-the-potential-cost-of-a-modification-of-the-legislation-concerning-medical-liability-phas-0

  11. [Effectiveness and cost-effectiveness of treatments for smoking cessation]

    KCE Reports 1 (2004) 22 juillet 2004 (1st print), août 2005 (2nd print)

    https://kce.fgov.be/en/effectiveness-and-cost-effectiveness-of-treatments-for-smoking-cessation

Pages